Literature DB >> 30608311

Prevalence of Medical and Psychiatric Comorbidities Following Traumatic Brain Injury.

Flora M Hammond1, John D Corrigan, Jessica M Ketchum, James F Malec, Kristen Dams-OʼConnor, Tessa Hart, Thomas A Novack, Jennifer Bogner, Marie N Dahdah, Gale G Whiteneck.   

Abstract

OBJECTIVE: To examine the prevalence of selected medical and psychiatric comorbidities that existed prior to or up to 10 years following traumatic brain injury (TBI) requiring acute rehabilitation.
DESIGN: Retrospective cohort.
SETTING: Six TBI Model Systems (TBIMS) centers. PARTICIPANTS: In total, 404 participants in the TBIMS National Database who experienced TBI 10 years prior.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURE: Self-reported medical and psychiatric comorbidities and the onset time of each endorsed comorbidity.
RESULTS: At 10 years postinjury, the most common comorbidities developing postinjury, in order, were back pain, depression, hypertension, anxiety, fractures, high blood cholesterol, sleep disorders, panic attacks, osteoarthritis, and diabetes. Comparing those 50 years and older to those younger than 50 years, diabetes (odds ratio [OR] = 3.54; P = .0016), high blood cholesterol (OR = 2.04; P = .0092), osteoarthritis (OR = 2.02; P = .0454), and hypertension (OR = 1.84; P = .0175) were significantly more prevalent in the older cohort while panic attacks (OR = 0.33; P = .0022) were significantly more prevalent in the younger cohort. No significant differences in prevalence rates between the older and younger cohorts were found for back pain, depression, anxiety, fractures, or sleep disorders.
CONCLUSIONS: People with moderate-severe TBI experience other medical and mental health comorbidities during the long-term course of recovery and life after injury. The findings can inform further investigation into comorbidities associated with TBI and the role of medical care, surveillance, prevention, lifestyle, and healthy behaviors in potentially modifying their presence and/or prevalence over the life span.

Entities:  

Mesh:

Year:  2019        PMID: 30608311      PMCID: PMC6602856          DOI: 10.1097/HTR.0000000000000465

Source DB:  PubMed          Journal:  J Head Trauma Rehabil        ISSN: 0885-9701            Impact factor:   2.710


  57 in total

1.  Head-injured subjects aged over 50 years: correlations between variables of trauma and neuropsychological follow-up.

Authors:  A Mazzucchi; R Cattelani; G Missale; M Gugliotta; R Brianti; M Parma
Journal:  J Neurol       Date:  1992-05       Impact factor: 4.849

2.  The magnitude and correlates of alcohol and drug use before traumatic brain injury.

Authors:  Charles H Bombardier; Carl T Rimmele; Heather Zintel
Journal:  Arch Phys Med Rehabil       Date:  2002-12       Impact factor: 3.966

3.  Headache after moderate and severe traumatic brain injury: a longitudinal analysis.

Authors:  William C Walker; Ronald T Seel; Glenn Curtiss; Deborah L Warden
Journal:  Arch Phys Med Rehabil       Date:  2005-09       Impact factor: 3.966

4.  A multi-center analysis of rehospitalizations five years after brain injury.

Authors:  J H Marwitz; D X Cifu; J Englander; W M High
Journal:  J Head Trauma Rehabil       Date:  2001-08       Impact factor: 2.710

5.  Heart rate variability (HRV) of patients with traumatic brain injury (TBI) during the post-insult sub-acute period.

Authors:  O Keren; S Yupatov; M M Radai; R Elad-Yarum; D Faraggi; S Abboud; H Ring; Z Groswasser
Journal:  Brain Inj       Date:  2005-08-10       Impact factor: 2.311

6.  Dysautonomia after traumatic brain injury: a forgotten syndrome?

Authors:  I J Baguley; J L Nicholls; K L Felmingham; J Crooks; J A Gurka; L D Wade
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-07       Impact factor: 10.154

7.  Validation of the Service Obstacles Scale for the traumatic brain injury population.

Authors:  Stephanie A. Kolakowsky-Hayner; Jeffrey S. Kreutzer; K. Dawn Miner
Journal:  NeuroRehabilitation       Date:  2000       Impact factor: 2.138

8.  Prediction of long-term occupational performance outcomes for adults after moderate to severe traumatic brain injury.

Authors:  R Devitt; A Colantonio; D Dawson; G Teare; G Ratcliff; S Chase
Journal:  Disabil Rehabil       Date:  2006-05-15       Impact factor: 3.033

9.  Posterior pituitary dysfunction after traumatic brain injury.

Authors:  Amar Agha; Evan Thornton; Patrick O'Kelly; William Tormey; Jack Phillips; Christopher J Thompson
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

10.  The effect of age on functional outcome in mild traumatic brain injury: 6-month report of a prospective multicenter trial.

Authors:  Anne C Mosenthal; David H Livingston; Robert F Lavery; Margaret M Knudson; Seong Lee; Diane Morabito; Geoffrey T Manley; Avery Nathens; Gregory Jurkovich; David B Hoyt; Raul Coimbra
Journal:  J Trauma       Date:  2004-05
View more
  19 in total

1.  Opioid Use among Individuals with Traumatic Brain Injury: A Perfect Storm?

Authors:  Rachel Sayko Adams; John D Corrigan; Kristen Dams-O'Connor
Journal:  J Neurotrauma       Date:  2019-08-16       Impact factor: 5.269

2.  Longitudinal Effects of Medical Comorbidities on Functional Outcome and Life Satisfaction After Traumatic Brain Injury: An Individual Growth Curve Analysis of NIDILRR Traumatic Brain Injury Model System Data.

Authors:  James F Malec; Jessica M Ketchum; Flora M Hammond; John D Corrigan; Kristen Dams-OʼConnor; Tessa Hart; Thomas Novack; Marie Dahdah; Gale G Whiteneck; Jennifer Bogner
Journal:  J Head Trauma Rehabil       Date:  2019 Sep/Oct       Impact factor: 2.710

3.  Development and Validation of a Functionally Relevant Comorbid Health Index in Adults Admitted to Inpatient Rehabilitation for Traumatic Brain Injury.

Authors:  Raj G Kumar; Xiaobo Zhong; Gale G Whiteneck; Madhu Mazumdar; Flora M Hammond; Natalia Egorova; Kirk Lercher; Kristen Dams-O'Connor
Journal:  J Neurotrauma       Date:  2021-11-24       Impact factor: 5.269

Review 4.  Post-Traumatic Epilepsy and Comorbidities: Advanced Models, Molecular Mechanisms, Biomarkers, and Novel Therapeutic Interventions.

Authors:  Victoria M Golub; Doodipala Samba Reddy
Journal:  Pharmacol Rev       Date:  2022-04       Impact factor: 25.468

Review 5.  Overview of Cochrane Systematic Reviews of Rehabilitation Interventions for Persons with Traumatic Brain Injury: A Mapping Synthesis.

Authors:  Vanessa M Young; Juan R Hill; Michele Patrini; Stefano Negrini; Chiara Arienti
Journal:  J Clin Med       Date:  2022-05-10       Impact factor: 4.964

6.  Health and cognition among adults with and without Traumatic Brain Injury: A matched case-control study.

Authors:  Raj G Kumar; Jessica M Ketchum; Flora M Hammond; Thomas A Novack; Therese M O'Neil-Pirozzi; Marc A Silva; Kristen Dams-O'Connor
Journal:  Brain Inj       Date:  2022-02-10       Impact factor: 2.167

7.  Traumatic brain injury, cardiovascular disease, and risk of dementia among older US Veterans.

Authors:  Erica Kornblith; Amber Bahorik; Yixia Li; Carrie B Peltz; Deborah E Barnes; Kristine Yaffe
Journal:  Brain Inj       Date:  2022-01-31       Impact factor: 2.167

8.  Concussion and Risk of Chronic Medical and Behavioral Health Comorbidities.

Authors:  Saef Izzy; Zabreen Tahir; Rachel Grashow; David J Cote; Ali Al Jarrah; Amar Dhand; Herman Taylor; Michael Whalen; David M Nathan; Karen K Miller; Frank Speizer; Aaron Baggish; Marc G Weisskopf; Ross Zafonte
Journal:  J Neurotrauma       Date:  2021-04-06       Impact factor: 4.869

9.  A Population-Based Study of Pre-Existing Health Conditions in Traumatic Brain Injury.

Authors:  Kristine C Dell; Emily C Grossner; Jason Staph; Philip Schatz; Frank G Hillary
Journal:  Neurotrauma Rep       Date:  2021-06-09

10.  Repetitive, mild traumatic brain injury results in a progressive white matter pathology, cognitive deterioration, and a transient gut microbiota dysbiosis.

Authors:  Mariana Angoa-Pérez; Branislava Zagorac; John H Anneken; Denise I Briggs; Andrew D Winters; Jonathan M Greenberg; Madison Ahmad; Kevin R Theis; Donald M Kuhn
Journal:  Sci Rep       Date:  2020-06-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.